Federated Hermes, Inc. Atara Biotherapeutics, Inc. Transaction History

Federated Hermes, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$0.23 - $1.74 $109 - $824	474 New	474 $0
Q4 2022 Feb 13, 2023	BUY	$2.85 - $5.18 $484 - $880	170 New	170 $0
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $702,208 - $903,228	-54,477 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$14.0 - $20.72 $762,678 - $1.13 Million	54,477 New	54,477 $782,000
Q3 2020 Nov 12, 2020	SELL	$11.92 - $15.87 $1.59 Million - $2.11 Million	-133,254 Closed	0 $0

Q2 2020 Aug 13, 2020	SELL	$7.53 - $14.93 $20.8 Million - $41.2 Million	-2,756,287 Reduced 95.39%	133,254 $1.94 Million
Q1 2020 May 13, 2020	BUY	$5.69 - $17.78 $3.44 Million - $10.8 Million	605,068 Added 26.49%	2,889,541 $24.6 Million
Q4 2019 Feb 14, 2020	BUY	$10.89 - $16.79 $640,408 - $987,369	58,807 Added 2.64%	2,284,473 $37.6 Million
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $14.4 Million - $23.9 Million	1,197,159 Added 116.4%	2,225,666 $31.4 Million
Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $2.39 Million - $5.14 Million	125,200 Added 13.86%	1,028,507 $20.7 Million
Q1 2019 May 10, 2019	BUY	$28.4 - $41.74 $8.27 Million - $12.2 Million	291,207 Added 47.58%	903,307 $35.9 Million
Q4 2018 Feb 13, 2019	BUY	$30.9 - $42.97 $4.22 Million - $5.87 Million	136,700 Added 28.75%	612,100 $21.3 Million
Q2 2018 Aug 10, 2018	SELL	$35.15 - $51.45 $40,106 - $58,704	-1,141 Reduced 0.24%	475,400 $17.5 Million
Q1 2018 May 09, 2018	BUY	$18.0 - $48.35 $8.58 Million - $23 Million	476,541 New	476,541 $18.6 Million

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.